Loomis, Sayles & Company’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,619,320
Closed -$44.8M 726
2024
Q3
$44.8M Buy
1,619,320
+300,076
+23% +$7.51M 0.06% 145
2024
Q2
$31.5M Buy
+1,319,244
New +$31M 0.04% 180

Other funds holding ASPN

Loomis, Sayles & Company's ASPN Position: Q4 2024 in Review

Loomis, Sayles & Company sold out of Aspen Aerogels (ASPN) in Q4 2024, closing a stake of 1,619,320 shares — an estimated $44.8M sold.

Loomis, Sayles & Company first reported a position in ASPN in Q2 2024 and held it in 2 quarters. The position peaked at $44.8M in Q3 2024. 231 funds tracked by Wall St. Rank hold ASPN as of Q4 2024.

  • Loomis, Sayles & Company reported no remaining Aspen Aerogels position as of Q4 2024 after selling out during the quarter.
  • Loomis, Sayles & Company sold 1,619,320 Aspen Aerogels shares in Q4 2024, an estimated $44.8M.
  • Loomis, Sayles & Company first reported a position in Aspen Aerogels in Q2 2024 and held it in 2 quarters.
  • Loomis, Sayles & Company's Aspen Aerogels position peaked at $44.8M in Q3 2024.
  • 231 funds tracked by Wall St. Rank held Aspen Aerogels as of Q4 2024.

Based on Loomis, Sayles & Company's 13F filing for Q4 2024, filed 12 Feb 2025.